Ophthalmic compositions for treating ocular hypertension

Details for Australian Patent Application No. 2004272546 (hide)

Owner Merck & Co., Inc.

Inventors Liu, Luping; Natarajan, Swaminathan; Chen, Meng Hsin; Tynebor, Robert M.; Doherty, James B.

Agent Spruson & Ferguson

Pub. Number AU-B-2004272546

PCT Pub. Number WO2005/026128

Priority 60/500,095 04.09.03 US

Filing date 31 August 2004

Wipo publication date 24 March 2005

Acceptance publication date 18 October 2007

International Classifications

A61P 27/06 (2006.01) Drugs for disorders of the senses

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/026128 Priority application(s): WO2005/026128

18 October 2007 Application Accepted

  Published as AU-B-2004272546

14 February 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272561-Process for the recovery of a phytolipid composition

2004272541-Tire inspection apparatus and method